All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Liver Fat Fraction and Machine Learning Improve Steatohepatitis Diagnosis in Liver Transplant Patients

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F25%3A00085690" target="_blank" >RIV/00023001:_____/25:00085690 - isvavai.cz</a>

  • Result on the web

    <a href="https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/nbm.70077" target="_blank" >https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/epdf/10.1002/nbm.70077</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/nbm.70077" target="_blank" >10.1002/nbm.70077</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Liver Fat Fraction and Machine Learning Improve Steatohepatitis Diagnosis in Liver Transplant Patients

  • Original language description

    This study investigates the diagnostic accuracy of liver fat fraction (FF) and other biomarkers in differentiating metabolic dysfunction-associated steatohepatitis (MASH) from non-MASH conditions in a cohort of 127 liver transplant patients using H-1 MRS and machine learning techniques. Receiver operating characteristic analysis identified FF as the most significant predictor, achieving an area under the curve (AUC) &gt; 0.96 for distinguishing MASH from non-steatosis and non-MASH metabolic dysfunction-associated steatotic liver disease (MASLD). Secondary biomarkers, including insulinemia and elastography, showed moderate discriminatory power (AUC = 0.7-0.8) and contributed to refining classification decisions within a decision tree model. The decision tree analysis, validated with 10-fold cross-validation and independent testing, demonstrated robust sensitivity and specificity, with FF contributing 60%-70% to decision-making. Secondary splits, such as insulinemia (similar to 16.21 mu IU/mL) and elastography (similar to 8 kPa), provided additional discriminatory power, particularly in cases with borderline FF values. Non-significant biomarkers, such as waist circumference and signals of diallylic protons resonating at 2.8 ppm, were excluded due to low discriminatory performance (AUC &lt; 0.7). Compared to the general population (similar to 5.8% prevalence), MASH was significantly more common in liver transplant recipients (similar to 30%-50%). In patients with FF &gt; 5.3%, the positive predictive value (PPV) for MASH ranged from 88% to 97%, more than twice the PPV observed in the general population (approximately 60%). These findings align with existing literature validating MRI-derived proton density fat fraction as a reliable biomarker for hepatic steatosis. However, liver fat percentage alone is insufficient for MASH diagnosis. Secondary biomarkers, particularly insulinemia and elastography, enhanced classification accuracy near the FF threshold of 5.3%. This multiparametric approach significantly improves diagnostic accuracy and addresses the elevated risk and unique clinical needs of liver transplant recipients. Overall, these results underscore the clinical utility and precision of MR spectroscopy as a noninvasive biomarker for MASH diagnosis in liver transplant patients.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30224 - Radiology, nuclear medicine and medical imaging

Result continuities

  • Project

    <a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2025

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    NMR in biomedicine

  • ISSN

    0952-3480

  • e-ISSN

    1099-1492

  • Volume of the periodical

    38

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    US - UNITED STATES

  • Number of pages

    11

  • Pages from-to

    "art. no. e70077"

  • UT code for WoS article

    001510018700009

  • EID of the result in the Scopus database

    2-s2.0-105007645072